Baxter International’s largest manufacturing plant is back up to regular production levels nearly five months after it was ...

A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...

Argus upgraded shares of Baxter International (NYSE:BAX – Free Report) from a hold rating to a buy rating in a report issued ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Months after Hurricane Helene, communities are still dealing with the aftermath. The Hurricane damaged Baxter International in North Carolina, a major supplier of IV fluids. Medical personnel have ...

Baxter International (NYSE:BAX – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from ...

Intravenous Solutions Market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031) BURLINGAME, CA, UNITED STATES ...